Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1987-03-19
1989-05-16
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
206569, 252645, A61K 4902, B65D 6900, C09K 1104
Patent
active
048308480
ABSTRACT:
A physiologically acceptable solution of tantalum-178 having an activity of 0.1 to 200 millicuries per milliliter of tantalum-178 solution is provided. The solution is obtained from tungsten-178 bound to a column of an anion exchange resin which forms tantalum-178 in situ by eluting the column with a hydrochloric acid solution containing hydrogen peroxide to form an acidic solution of tantalum-178. The acidic solution of tantalum-178 then is neutralized.
REFERENCES:
Holman et al, Chemical Abstracts, vol. 89 (Jul. 10, 1978), No. 13472t.
Davis Michael A.
Harris Gale I.
Holman B. Leonard
Neirinckx Rudi D.
Cook Paul J.
Maples John S.
Massachusetts Institute of Technology
LandOfFree
Radiopharmaceutical composition containing tantalum-178 and proc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopharmaceutical composition containing tantalum-178 and proc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceutical composition containing tantalum-178 and proc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2321238